NFID Announces 2020-2021 Board of Directors
Bethesda, MD (July 9, 2020) — The National Foundation for Infectious Diseases (NFID) is pleased to announce the 2020-2021 NFID Board of Directors and updated slate of officers, including NFID President Patricia N. Whitley-Williams, MD, of Rutgers Robert Wood Johnson Medical School in New Brunswick, NJ; President-Elect Patricia A. Stinchfield, RN, MS, CPNP, CIC, of Children’s Minnesota; and Vice President Jeffery A. Goad, PharmD, MPH, of Chapman University School of Pharmacy in Irvine, CA.
Dr. Whitley-Williams is professor of pediatrics; chief of the Division of Pediatric Allergy, Immunology, and Infectious Diseases; and associate dean of inclusion and diversity at Rutgers Robert Wood Johnson Medical School.
“In the midst of the COVID-19 pandemic, the mission of NFID to educate the public and healthcare professionals about the prevention and treatment of infectious diseases has never been more important,” said Dr. Whitley-Williams. “The COVID-19 pandemic has shed new light on longstanding disparities in health outcomes among African-Americans and other minority populations, and has underscored the importance of addressing myths and misconceptions about vaccine safety and efficacy. The challenges we face are substantial, but working together, we can meet them head on.”
A native of Boston, she received a bachelor of science degree in biology from Simmons College in Boston and medical degree from Johns Hopkins University School of Medicine. She completed her pediatric residency at Children’s Hospital Medical Center in Cincinnati and fellowship training in pediatric infectious diseases at Boston City Hospital/Boston University School of Medicine. Dr. Whitley-Williams is board certified in pediatrics and pediatric infectious diseases and is a fellow of the American Academy of Pediatrics. She serves as the National Medical Association liaison to the Advisory Committee on Immunization Practices (ACIP) at the Centers for Disease Control and Prevention (CDC), and is immediate past chair of the US Medical Licensure Examination Management Committee as well as a member of the National Board of Medical Examiners Governance Review Task Force and Nominating Committee. Her research interests include HIV/AIDS in women and children as well as childhood and adolescent immunizations.
Patricia (Patsy) Stinchfield has been a pediatric nurse practitioner for more than 30 years. She specializes in infectious disease and infection prevention at Children’s Minnesota and is the senior director of infection control and program director for The Children’s Immunization Project, a collaborative effort in Minnesota bringing immunization information to parents, providers, and the community. She was lead author of a recent NFID report on Vitamin A for the Management of Measles in the US.
“A virus such as measles or coronavirus doesn’t care what color you are, what degree you have, where you live, or where you’re from. It only cares that you’re not immune, and it will seek and find those individuals and infect them at a very high rate,” says Stinchfield. “That’s why we vaccinate, and it’s why the work of NFID is so important.”
Stinchfield is a past voting member and current liaison to ACIP, representing the National Association of Pediatric Nurse Practitioners). She serves as an associate clinical faculty member at the University of Minnesota’s School of Nursing and sits on the Minnesota Department of Health Immunization Advisory Committee. A frequent spokesperson on immunization topics for local and national media outlets, she is a graduate of Moorhead State University and the University of Utah School of Nursing.
Dr. Goad is professor and chair of the Department of Pharmacy Practice at the Chapman University School of Pharmacy. He received his doctor of pharmacy degree from the University of Southern California (USC) School of Pharmacy and master of public health from the Keck School of Medicine at USC. He completed a residency in pediatric pharmacy practice at Children’s Hospital Los Angeles and holds the Certificate of Knowledge in Travel Health from the International Society of Travel Medicine. For more than 20 years, Dr. Goad has maintained an active practice in travel medicine and immunization services. He coordinates and teaches courses in travel medicine, immunizations, and parasitology. He is currently a national faculty and advisory board member for the American Pharmacists Association (APhA) Pharmacy-Based Immunization Training Program and chair of the APhA Travel Medicine Advanced Competency Training Course.
Dr. Goad is the past chair and co-founder of the International Society of Travel Medicine’s Pharmacist Professional Group and past president of the California Immunization Coalition and California Pharmacists Association.
Other new members of the NFID Board of Directors include Tamera Coyne-Beasley, MD, MPH, of the University of Alabama Birmingham; Julie Morita, MD, of the Robert Wood Johnson Foundation; and S. Shaefer Spires, MD, of Duke University Hospital. Cristina Cassetti, PhD, of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (Federal Liaison), and Kathleen M. Neuzil, MD, MPH, of the Center for Vaccine Development, University of Maryland School of Medicine have been re-elected to serve additional three-year terms.
A complete list of 2020-2021 NFID Board of Directors is below. This esteemed group of public health leaders officially began responsibilities on July 1, 2020. As the governing body, the Board of Directors establishes the strategic direction for NFID, ensures that annual goals are met, and provides financial oversight.
The NFID Board of Directors also expresses its appreciation to outgoing Past President Walter A. Orenstein, MD, of Emory Vaccine Center, who served in various NFID leadership roles over many years, and outgoing Director Beth P. Bell, MD, MPH, of the University of Washington School of Public Health for their contributions to NFID.
2020-2021 NFID Board of Directors
- Joseph A. Bocchini, Jr., MD, Immediate Past-President, Willis-Knighton Health System
- Cristina Cassetti, PhD, National Institute of Allergy and Infectious Diseases, National Institutes of Health (Federal Liaison)
- Sara E. Cosgrove, MD, MS, Johns Hopkins University School of Medicine
- Tamera Coyne-Beasley, MD, MPH, University of Alabama Birmingham
- Monica M. Farley, MD, Emory University School of Medicine
- Jeffery A. Goad, PharmD, MPH, Vice President, Chapman University School of Pharmacy
- Lisa S. Ipp, MD, Weill Cornell Medicine, New York-Presbyterian
- Ruth Lynfield, MD, Minnesota Department of Health
- Julie Morita, MD, Robert Wood Johnson Foundation
- Kathleen M. Neuzil, MD, MPH, Center for Vaccine Development, University of Maryland School of Medicine
- Kevin Rooney, Treasurer, QOL Medical
- S. Shaefer Spires, MD, Duke University Hospital
- Patricia A. Stinchfield, RN, MS, CPNP, CIC, President-Elect, Children’s Minnesota
- H. Keipp B. Talbot, MD, MPH, Secretary, Vanderbilt University School of Medicine
- Patricia N. Whitley-Williams, MD, President, Rutgers Robert Wood Johnson Medical School
- Cynthia G. Whitney, MD, MPH, Emory University
Marla Dalton, PE, CAE, Executive Director & CEO
Richard J. Duma, MD, PhD, Director Emeritus
William Schaffner, MD, Medical Director
About the National Foundation for Infectious Diseases
Founded in 1973, the National Foundation for Infectious Diseases (NFID) is a non-profit 501(c)(3) organization dedicated to educating the public and healthcare professionals about the burden, causes, prevention, diagnosis, and treatment of infectious diseases across the lifespan. For additional information, visit www.nfid.org.
Contact: Diana Olson, National Foundation for Infectious Diseases, email@example.com, (301) 656-0003×140